TriangleFOR PATIENTS · SOURCE READING
Single-System and Multisystem Disease
Source: Langerhans Cell Histiocytosis Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: June 6, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment of LCH in Adults
Treatment of single-system and multisystem disease in adults that does not affect the lung, bone, or skin may include:
Source links and citations
Chemotherapy.
Source links and citations
Radiation therapy.
Source links and citations
Targeted therapy (vemurafenib).
Source links and citations
For more about LCH trials for adults, see the Histiocyte Society website.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice